Pédiatrie Tumeurs solides CDRB436G2401 An open label, multi-center roll-over study to assess longterm;effect in pediatric patients treated with Tafinlar;(dabrafenib) and/or Mekinist (trametinib) Paris FRANCOIS DOZ